SELLAS Life Sciences GAAP EPS of -$0.05 in-line
Tickers: $SLS
Read the full article at Seeking Alpha
Part of the story SELLAS Life Sciences Group, Inc. - 8-K Filing (4 articles)
More World news
- Robinhood Reports Increase in Funded Customers Amidst Slight Decline in Platform Assets
- Imunon Sets Enrollment and Interim Analysis Timelines for OVATION-3 Clinical Trial
- Sensus Healthcare Reports Q3 Earnings Miss on Lower Revenue and Negative EPS
- Lulu's Fashion Lounge Reports Q3 2026 Revenue Decline and Lowered Full-Year Guidance
- DeFi Technologies Reports Q3 2026 Revenue of $18.3 Million and Operating Income of $7.0 Million
- Wolverine World Wide Raises Revenue Outlook Following Strong Q3 Growth
- Nexxen Reaffirms 2026 Guidance and Projects High Future EBITDA Margins
- Corvex Announces 6.2 MW Capacity Target for Q4 2026 and Blackwell Offtake Negotiations
- Arcos Dorados Announces Long-Term Growth Targets and $25 Million Share Buyback
- Westport Fuel Systems Reports Q3 Earnings Beat on Revenue and EPS